Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation

• Published in: International journal of molecular sciences Vol. 24; no. 3; p. 2918
• Main Authors: Mollo, Nunzia, Scognamiglio, Roberta, Conti, Anna, Paladino, Simona, Nitsch, Lucio, Izzo, Antonella
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 02.02.2023; MDPI
• Subjects: Animals; Cell adhesion & migration; Chromosome 21; Chromosomes; Chromosomes, Human, Pair 21 - genetics; Collagen; congenital heart defects; Disease Models, Animal; Down syndrome; Down Syndrome - complications; Down Syndrome - genetics; Down's syndrome; Extracellular matrix; Extracellular Matrix - genetics; Fetuses; Genes; Genotype & phenotype; Heart; Heart Defects, Congenital - genetics; Humans; Kinases; MicroRNAs - genetics; Molecular modelling; Morphogenesis; Mutation; Pathogenesis; Phosphatase; Phosphorylation; Proteins; Review; RUNX1; Runx1 protein; Stem cells; Trisomy; Down syndrome; chromosome 21; extracellular matrix; RUNX1; congenital heart defects
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24032918

Down syndrome (DS), a complex disorder that is caused by the trisomy of chromosome 21 (Hsa21), is a major cause of congenital heart defects (CHD). Interestingly, only about 50% of individuals with Hsa21 trisomy manifest CHD. Here we review the genetic basis of CHD in DS, focusing on genes that regulate extracellular matrix (ECM) organization. The overexpression of Hsa21 genes likely underlies the molecular mechanisms that contribute to CHD, even though the genes responsible for CHD could only be located in a critical region of Hsa21. A role in causing CHD has been attributed not only to protein-coding Hsa21 genes, but also to genes on other chromosomes, as well as miRNAs and lncRNAs. It is likely that the contribution of more than one gene is required, and that the overexpression of Hsa21 genes acts in combination with other genetic events, such as specific mutations or polymorphisms, amplifying their effect. Moreover, a key function in determining alterations in cardiac morphogenesis might be played by ECM. A large number of genes encoding ECM proteins are overexpressed in trisomic human fetal hearts, and many of them appear to be under the control of a Hsa21 gene, the RUNX1 transcription factor.